cerrar
Tagged with RMAC

Luxembourg: A Healthcare Logistics Leader
Sound infrastructure, a prime location in the heart of Europe, government support, and an unwavering focus on quality are all helping make the tiny…

Athanasios Athanasiadis – Head of Health Economics…
With extensive experience in the field of health economics, IOBE’s Head of the Health Economics Observatory, Thanos Athanasiadis, discusses the…

Interview: Grace Yeh – Founder, President & CEO,…
Grace Yeh, Founder, President, and CEO of PharmaEngine, one of the most eye-catching success stories to recently emerge from Taiwan’s maturing…

Interview: Dr. Ignazio Cassis – President, curafutura…
Switzerland may have a world class healthcare system, but small adjustments are needed to ensure incentives for payer and providers are properly…

Interview: Thomas Früh – CEO, Bachem, Switzerland
Advances in delivery technology and manufacturing costs have driven a surge of activity in peptide drug development, says Thomas Früh, CEO of Bachem…

Interview: Nestor Lumanas – General Manager, Sannovex,…
In an exclusive interview with Nestor Lumanas, the founder and general manager of Sannovex in the Philippines, he highlights their impeccable sales…

Interview: John Davison – CEO, Zuellig Pharma
In an exclusive interview, Zuellig Pharma CEO John Davison provides insight into the new Zuellig Health Solutions unit that is providing strategic,…

Interview: Ebb Hinchliffe – Executive Director, The…
Ebb Hinchliffe, Executive Director of the American Chamber of Commerce of the Philippines, discusses the Chamber’s current advocacy efforts in the…

Interview: Daniel Pedrett – CEO, Rohner Chem, Switzerland
Outsourcing of API synthesis has stabilized in the decade since Rohner Chem entered the pharma sector in earnest, and according to CEO Daniel Pedrett…

Pure Play vs. Diversification
"We are witnessing many instances where pharma companies are shrinking to grow.”

Interview: Gerrard McKenna – Country Managing Director,…
Boehringer Ingelheim’s (BI) country managing director in South East Asia and South Korea (SEASK), Gerrard McKenna characterizes the recent changes…

The Servier Way
Shedding light on the unique business model of French pharma’s most successful mid-cap. Not long ago, Laboratories Servier was…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here